Keun‐Wook Lee

15.7k total citations · 2 hit papers
265 papers, 7.3k citations indexed

About

Keun‐Wook Lee is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Keun‐Wook Lee has authored 265 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 172 papers in Oncology, 109 papers in Pulmonary and Respiratory Medicine and 62 papers in Surgery. Recurrent topics in Keun‐Wook Lee's work include Gastric Cancer Management and Outcomes (75 papers), Colorectal Cancer Treatments and Studies (61 papers) and Cancer Immunotherapy and Biomarkers (32 papers). Keun‐Wook Lee is often cited by papers focused on Gastric Cancer Management and Outcomes (75 papers), Colorectal Cancer Treatments and Studies (61 papers) and Cancer Immunotherapy and Biomarkers (32 papers). Keun‐Wook Lee collaborates with scholars based in South Korea, United States and Japan. Keun‐Wook Lee's co-authors include Jee Hyun Kim, Yung‐Jue Bang, Soo‐Mee Bang, Jin Won Kim, Yeul Hong Kim, Y. Choi, Hyun Cheol Chung, Jong Seok Lee, Jeong‐Ok Lee and Yu Jung Kim and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Keun‐Wook Lee

254 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

2012 1.2k citations Yung‐Jue Bang, Hyun Cheol Chung et al. profile →
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial

2017 429 citations Keun‐Wook Lee et al. profile →

Peers

Countries citing papers authored by Keun‐Wook Lee

Since Specialization

Citations

This map shows the geographic impact of Keun‐Wook Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keun‐Wook Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keun‐Wook Lee more than expected).

Fields of papers citing papers by Keun‐Wook Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keun‐Wook Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keun‐Wook Lee. The network helps show where Keun‐Wook Lee may publish in the future.

Co-authorship network of co-authors of Keun‐Wook Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Keun‐Wook Lee. A scholar is included among the top collaborators of Keun‐Wook Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keun‐Wook Lee. Keun‐Wook Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	First-Line Tislelizumab Plus Chemotherapy for Advanced Gastric Cancer with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-305 2025 ·Advances in Therapy ·Markus Moehler, Do‐Youn Oh, Ken Kato, Hendrik‐Tobias Arkenau, Josep Tabernero, Keun‐Wook Lee, Sun Young Rha, Hidekazu Hirano, David R. Spigel, Kensei Yamaguchi, Lucjan Wyrwicz, Umut Dişel, Roberto Pazo-Cid, Lorenzo Fornaro, Yaling Xu, Tao Sheng, Silu Yang, (unknown), Marcia Cruz‐Correa, Rui‐Hua Xu	2
2	Skeletal-Related Events in Patients With Multiple Myeloma: A Comprehensive Retrospective Cohort Study 2024 ·Journal of Korean Medical Science ·Ji Yun Lee, Ju Hyun Lee, (unknown), Min-Su Kang, Eun Hee Jung, (unknown), Koung Jin Suh, Ji‐Won Kim, Se Hyun Kim, Jeong‐Ok Lee, Jin Won Kim, Yu Jung Kim, Keun‐Wook Lee, Jee Hyun Kim, Jong Seok Lee, Soo‐Mee Bang	1
3	Liquid Biopsy: An Emerging Diagnostic, Prognostic, and Predictive Tool in Gastric Cancer 2024 ·Journal of the Korean Gastric Cancer Association ·Hye Sook Han, Keun‐Wook Lee	18
4	Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01) 2023 ·Cancers ·Yun‐Gyoo Lee, Eun Joo Kang, Bhumsuk Keam, (unknown), Jin-Soo Kim, Keon Uk Park, Kyoung Eun Lee, Keun‐Wook Lee, Min Kyoung Kim, Hee Kyung Ahn, Seong Hoon Shin, Hye Ryun Kim, Sung‐Bae Kim, Hyo Jung Kim, Hwan‐Jung Yun	0
5	Genomic and Transcriptomic Characterization of Gastric Cancer with Bone Metastasis 2023 ·Cancer Research and Treatment ·Soo Jin Oh, Soo Kyung Nam, Keun‐Wook Lee, Hye Seung Lee, Yujun Park, Yoonjin Kwak, Kyu Sang Lee, Ji‐Won Kim, Jin Won Kim, Min-Su Kang, Young Suk Park, (unknown), Yun‐Suhk Suh, Do Joong Park, Hyung‐Ho Kim	8
6	Artificial intelligence‐powered spatial analysis of tumor‐infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma 2023 ·Head & Neck ·(unknown), Yoojoo Lim, Chan‐Young Ock, Gahee Park, Seonwook Park, (unknown), Minuk Ma, (unknown), Eun Joo Kang, Myung‐Ju Ahn, Keun‐Wook Lee, Jung Hye Kwon, Yaewon Yang, Yoon Hee Choi, Min Kyoung Kim, Jun Ho Ji, Tak Yun, (unknown), Bhumsuk Keam	5
7	Clinical characteristics and disease course of splanchnic vein thrombosis in gastrointestinal cancers: A prospective cohort study 2022 ·PLoS ONE ·Min-Su Kang, Koung Jin Suh, Ji‐Won Kim, Ja Min Byun, Jin Won Kim, Ji Yun Lee, Jeong‐Ok Lee, Soo‐Mee Bang, Yu Jung Kim, Se Hyun Kim, Jee Hyun Kim, Jong Seok Lee, Keun‐Wook Lee	3
8	A Phase II Study of Nivolumab plus Gemcitabine in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma (KCSG HN17–11) 2022 ·Clinical Cancer Research ·Hyun Ae Jung, Keon Uk Park, Sang‐Hee Cho, Jinyeong Lim, Keun‐Wook Lee, Min Hee Hong, Tak Yun, Ho Jung An, Woong‐Yang Park, Sérgio Pereira, Chan‐Young Ock, Bhumsuk Keam	18
9	Trastuzumab Deruxtecan in Anti–Human Epidermal Growth Factor Receptor 2 Treatment–Naive Patients With Human Epidermal Growth Factor Receptor 2–Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II Trial 2022 ·Journal of Clinical Oncology ·Kensei Yamaguchi, Yung‐Jue Bang, Satoru Iwasa, Naotoshi Sugimoto, Min‐Hee Ryu, Daisuke Sakai, Hyun Cheol Chung, Hisato Kawakami, Hiroshi Yabusaki, Jeeyun Lee, Tatsu Shimoyama, Keun‐Wook Lee, Kaku Saito, Yoshinori Kawaguchi, Takahiro Kamio, (unknown), Masahiro Sugihara, Kohei Shitara	76
10	Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study 2022 ·Clinical Cancer Research ·Keun‐Wook Lee, Eric Van Cutsem, Yung‐Jue Bang, Charles S. Fuchs, Iveta Kudaba, Marcelo Garrido, Hyun Cheol Chung, Jeeyun Lee, Hugo R. Castro, Joseph Chao, Zev A. Wainberg, Z. Alexander Cao, Deepti Aurora-Garg, Julie Kobie, Răzvan Cristescu, Pooja Bhagia, Sukrut Shah, Josep Tabernero, Kohei Shitara, Lucjan Wyrwicz	55
11	Performance of clinician prediction of survival in oncology outpatients with advanced cancer 2022 ·PLoS ONE ·Yu Jung Kim, (unknown), Sang‐Yeon Suh, Yusuke Hiratsuka, Beodeul Kang, (unknown), Hong Yup Ahn, Koung Jin Suh, Ji‐Won Kim, Se Hyun Kim, Jin Won Kim, Keun‐Wook Lee, Jee Hyun Kim, Jong Seok Lee	7
12	Randomized double-blind placebo-controlled phase 2 study of bemarituzumab combined with modified FOLFOX6 (mFOLFOX6) in first-line (1L) treatment of advanced gastric/gastroesophageal junction adenocarcinoma (FIGHT). 2021 ·Journal of Clinical Oncology ·Zev A. Wainberg, Peter C. Enzinger, Yoon‐Koo Kang, Kensei Yamaguchi, Shukui Qin, Keun‐Wook Lee, Sang Cheul Oh, Jin Li, Hacı Mehmet Türk, Alexandra Teixeira, Giovanni Gerardo Cardellino, (unknown), Siddhartha Mitra, Yingsi Yang, Helen Collins, Daniel V.T. Catenacci	63
13	Randomized Phase II Study of Axitinib versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma 2021 ·Clinical Cancer Research ·Eun Joo Kang, Myung‐Ju Ahn, Chan-Young Ock, Keun‐Wook Lee, Jung Hye Kwon, Yaewon Yang, Yoon Hee Choi, Min Kyoung Kim, Jun Ho Ji, Tak Yun, Byung‐Ho Nam, Sung‐Bae Kim, Bhumsuk Keam	39
14	Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study 2018 ·PLoS ONE ·In Sil Choi, (unknown), Ju Hyun Lee, Jee Hyun Kim, Koung Jin Suh, Ji Yun Lee, Beodeul Kang, Ji‐Won Kim, Se Hyun Kim, Jin Won Kim, Jeong‐Ok Lee, Yu Jung Kim, Soo‐Mee Bang, Jong Seok Lee, Keun‐Wook Lee	18
15	Effect of Early Adjuvant Chemotherapy on Survival of Advanced Gastric Cancer Patients: a Propensity Score-matched Analysis 2018 ·Journal of the Korean Gastric Cancer Association ·Yoontaek Lee, Sa-Hong Min, Ki Bum Park, Young Suk Park, Ji‐Won Kim, Sang-Hoon Ahn, Jin Won Kim, Do Joong Park, Keun‐Wook Lee, Hyung‐Ho Kim	11
16	A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study 2018 ·PLoS ONE ·In Sil Choi, Jee Hyun Kim, Ju Hyun Lee, Koung Jin Suh, Ji Yun Lee, (unknown), Se Hyun Kim, Jin Won Kim, Jeong‐Ok Lee, Yu Jung Kim, Soo‐Mee Bang, Jong Seok Lee, Keun‐Wook Lee	8
17	Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer 2015 ·Clinical Cancer Research ·Chan-Young Ock, Keun‐Wook Lee, Jin Won Kim, Jin-Soo Kim, Tae‐Yong Kim, Kyung-Hun Lee, Sae‐Won Han, Seock‐Ah Im, Tae-You Kim, Woo Ho Kim, Yung‐Jue Bang, Do‐Youn Oh	52
18	Significant Association of Oncogene YAP1 with Poor Prognosis and Cetuximab Resistance in Colorectal Cancer Patients 2014 ·Clinical Cancer Research ·Keun‐Wook Lee, Sung Sook Lee, Sang-Bae Kim, Bo Hwa Sohn, Hyun‐Sung Lee, Hee-Jin Jang, Yun‐Yong Park, Scott Kopetz, Sung Soo Kim, Sang Cheul Oh, Ju‐Seog Lee	132
19	Prevalence and Risk Factors for Iron Deficiency Anemia in the Korean Population: Results of the Fifth Korea National Health and Nutrition Examination Survey 2014 ·Journal of Korean Medical Science ·Jeong‐Ok Lee, Ju Hyun Lee, Soyeon Ahn, Jin Won Kim, Hyun Chang, Yu Jung Kim, Keun‐Wook Lee, Jee Hyun Kim, Soo‐Mee Bang, Jong Seok Lee	53
20	Enzastaurin, a Protein Kinase Cβ Inhibitor, Suppresses Signaling through the Ribosomal S6 Kinase and Bad Pathways and Induces Apoptosis in Human Gastric Cancer Cells 2008 ·Cancer Research ·Keun‐Wook Lee, Sang Gyun Kim, Hwang‐Phill Kim, Euna Kwon, (unknown), (unknown), Jung‐Hyun Park, Byeong‐Cheol Kang, Seock‐Ah Im, Tae‐You Kim, Woo Ho Kim, Yung‐Jue Bang	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact